FindTrial
Sign In

Study on intraoperative imaging of pulmonary nodules with Indocyanine Green Inhalation

Mechanism and clinical application of targeted inhalation of indocyanine green in intraoperative imaging of pulmonary nodules

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053708
Enrollment
Unknown
Registered
2021-11-27
Start date
2022-01-14
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

green&#32
can&#32
detect&#32
pulmonary&#32
nodules&#32
during&#32
surgery.
Gold Standard:Pathological results, including H&E staining section microscopy, frozen section microscopy and immunofluorescence microscopy.
Index test:Access&#32
whether&#32
the&#32
targeted&#32
inhalation&#32
of&#32
indocyanine&#32

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with pulmonary nodules within 2cm from the visceral pleura in CT scans; 2.Patients intended to underwent lobectomy; 3.Patients himself voluntarily signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients who are allergic to ICG; 2.Patients with inadequate specimens for pathological examination; 3.The nodule is pathological benign disease; 4.Patients with infectious disease (Hepatitis B, Hepatitis C, syphilis, AIDS and so on); 5.Patients deemed unsuitable by the investigator.

Design outcomes

Primary

MeasureTime frame
Detection rates of lung nodes with fluorescence imaging;—

Secondary

MeasureTime frame
The signal-to- background ratio;—

Countries

China

Contacts

Public ContactZhou Jian

Peking University People's Hospital

zhoujian@bjmu.edu.cn+86 13811765740

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026